Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (11-20 of 272) with videos related to

Pageof 28
Sort By:
The Lancet. Oncology|December 17, 2004
Clinical trial design in oncology: statistical powerCiro Gallo, Francesco Perrone
Clinics in Liver Disease|April 16, 2005
Staging for liver cancerBruno Daniele, Francesco Perrone
Recenti Progressi in Medicina|December 21, 2016
[Unpleaseant news.]Francesco Perrone, Ciro Gallo
The Lancet. Oncology|February 3, 2009
Palonosetron: more than just another option?Massimo Di Maio, Francesco Perrone
The Lancet. Oncology|June 2, 2009
Registrative trials of antiemetic drugs: arrival or starting point?Massimo Di Maio, Francesco Perrone
Health and Quality of Life Outcomes|October 4, 2003
Quality of Life in elderly patients with cancerMassimo Di Maio, Francesco Perrone
Tumori|May 7, 2002
Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)? ProFrancesco Perrone, Ermelinda De Maio
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Subgroup Analysis: Refining a Positive Result or Trying to Rescue a Negative One?Massimo Di Maio, Francesco Perrone
Journal of the National Cancer Institute|July 4, 2002
Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trialFrancesco Perrone, Ciro Gallo, Cesare Gridelli
Cancers|June 10, 2023
Pitfalls in OncogeriatricsSilvio Monfardini, Francesco Perrone, Lodovico Balducci
Pageof 28

Showing results (11-20 of 272) with videos related to

Sort By:
Pageof 28
The Lancet. Oncology|December 17, 2004
Clinical trial design in oncology: statistical powerCiro Gallo, Francesco Perrone
Clinics in Liver Disease|April 16, 2005
Staging for liver cancerBruno Daniele, Francesco Perrone
Recenti Progressi in Medicina|December 21, 2016
[Unpleaseant news.]Francesco Perrone, Ciro Gallo
The Lancet. Oncology|February 3, 2009
Palonosetron: more than just another option?Massimo Di Maio, Francesco Perrone
The Lancet. Oncology|June 2, 2009
Registrative trials of antiemetic drugs: arrival or starting point?Massimo Di Maio, Francesco Perrone
Health and Quality of Life Outcomes|October 4, 2003
Quality of Life in elderly patients with cancerMassimo Di Maio, Francesco Perrone
Tumori|May 7, 2002
Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)? ProFrancesco Perrone, Ermelinda De Maio
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Subgroup Analysis: Refining a Positive Result or Trying to Rescue a Negative One?Massimo Di Maio, Francesco Perrone
Journal of the National Cancer Institute|July 4, 2002
Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trialFrancesco Perrone, Ciro Gallo, Cesare Gridelli
Cancers|June 10, 2023
Pitfalls in OncogeriatricsSilvio Monfardini, Francesco Perrone, Lodovico Balducci
Pageof 28